Sign in
4

Changes in Ownership

Protagenic Therapeutics, Inc.\new Filed Acc 0001144204-10-004581

Options or other derivatives

  • Chief Executive Officer acquired 1,000,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

SCHWARTZ JEFFREY A · Chief Executive Officer

Table II: Derivative

2 lines
Date Transaction Shares Owned after D/I
2010-01-27 Grant or award : show line 1 in the form Stock Option (Right to Buy) +500,000 500,000 D
2010-01-27 Grant or award : show line 2 in the form Stock Option (Right to Buy) +500,000 500,000 D
Loading xslF345X03/v172784_ex.xml…